Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04530552Phase 2Completed
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
PrincipalinvestigatorStart date: 2021-07-23

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Arizona Cancer Center - Prevention Research Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Woodrum, MD, PhD

Mayo Clinic

Moderately Similar
5 trials

Shared therapeutic areas:

Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
Similarity Score30%

Robert Montgomery

Fred Hutch/University of Washington Cancer Consortium

Related
6 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Amar Kishan

UCLA / Jonsson Comprehensive Cancer Center

Related
7 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8Stage I Prostate Cancer AJCC v8
Similarity Score23%

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

Related
9 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Kerri Winters-Stone

OHSU Knight Cancer Institute

Related
8 trials

Shared therapeutic areas:

Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Lorna McNeill

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Prostate Adenocarcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Roxana S. Dronca, MD

Mayo Clinic

Related
4 trials

Shared therapeutic areas:

Prostate Adenocarcinoma
Similarity Score8%

Steven Chmura, MD

University of Chicago

Related
5 trials

Shared therapeutic areas:

Prostate Adenocarcinoma
Similarity Score8%

Carlos E. Vargas, M.D.

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Prostate Adenocarcinoma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04530552Phase 2PrincipalInvestigator

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
Completed

All 1 trials loaded